-
ReoPro Stroke Trial Halted by Lilly and J&J Due To Emerging Safety Issue
Higher Risk of Brain Hemorrhage In Acute Ischemic Stroke Patients Treated With ReoPro On October 28, 2005 Eli Lilly & Co. and Johnson & Johnson’s Centocor unit announced that they had permanently stopped a…
-
Increasing Number of New Drug Trials Are Ended Early Due To Benefits Found
The Downside: Potential Safety Problems May Remain Hidden Until Later The "News roundup" section of the November 12, 2005 edition of the British Medical Journal ("BMJ") included an article by Michael Day about how…
-
Safety Warning Issued For Ortho Evra Birth Control Skin Patch
FDA: Possible Increased Risk of Blood Clots For Ortho Evra Users In November 2005 the FDA announced that it had approved an updated label, or package insert, for the Ortho Evra contraceptive patch. The…
-
Danish Study Suggests Celebrex And Vioxx To Be Avoided After Heart Attack
Increased Risk Of Death For Post-Heart Attack Patients Taking COX-2 Drugs In mid-November 2005 it was reported that Merck’s Vioxx and Pfizer’s Celebrex, as well as some similar painkillers, increase the risk of death…
-
Celebrex and Bextra Federal Court MDL Cases Will Go To California
Product Liability and Sales Claims Assigned To Judge Breyer in San Francisco In Fall 2005 all federal court cases involving Pfizer Inc.’s painkillers Celebrex and Bextra were consolidated into a multi-district litigation (MDL) and…
-
Hormone Replacement Therapy With Alcohol Use Increases Breast Cancer Risk
November 2005 HRT-Alcohol Study Attempts To Find Out More About Mechanism Women who use postmenopausal hormone replacement therapy drugs and, at the same time, use alcohol are apparently at an increased risk of developing…
